Marmorino, Federica
Salvatore, Lisa
Barbara, Cecilia
Allegrini, Giacomo
Antonuzzo, Lorenzo
Masi, Gianluca
Loupakis, Fotios
Borelli, Beatrice
Chiara, Silvana
Banzi, Maria Chiara
Miraglio, Emanuela
Amoroso, Domenico
Dargenio, Francesco
Bonetti, Andrea
Martignetti, Angelo
Paris, Myriam
Tomcikova, Daniela
Boni, Luca
Falcone, Alfredo
Cremolini, Chiara
Article History
Received: 8 August 2016
Revised: 15 November 2016
Accepted: 16 November 2016
First Online: 12 January 2017
Competing interests
: LA reports serving on advisory board or having consultant role for Roche, Amgen, Eli-Lilly, Bayer, Novartis, Ipsen; FL reports serving on advisory board for Amgen and Sanofi-Aventis, receiving lecture fees from Sanofi-Aventis, Bayer, Roche and grant support from Roche and Merck Serono; AF reports serving on advisory board for Amgen, Bayer, Merck Serono, Roche and Sanofi-Aventis, receiving lecture fees from Merck Serono, Roche, Amgen, Bayer, Amgen, Bayer, Merck Serono, Roche and Sanofi-Aventis and grant support from Amgen, Merck Serono and Roche; CC reports serving on advisory board for Roche, Bayer, Amgen and Merck Serono and receiving lecture fees from Sanofi-Aventis and Bayer. All remaining authors declared no conflicts of interest.